Your browser is no longer supported. Please, upgrade your browser.
BrainsWay Ltd.
Index- P/E- EPS (ttm)-0.48 Insider Own1.96% Shs Outstand16.45M Perf Week0.08%
Market Cap141.92M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float11.24M Perf Month-7.33%
Income- PEG- EPS next Q-0.06 Inst Own13.46% Short Float0.16% Perf Quarter8.25%
Sales22.06M P/S6.43 EPS this Y45.80% Inst Trans- Short Ratio0.19 Perf Half Y48.75%
Book/sh1.76 P/B4.89 EPS next Y46.20% ROA- Target Price14.10 Perf Year1.37%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range5.52 - 11.04 Perf YTD14.42%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-21.85% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low56.29% ATR0.39
Employees100 Current Ratio- Sales Q/Q12.30% Oper. Margin- RSI (14)47.86 Volatility3.56% 4.66%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.12 Prev Close8.33
ShortableYes LT Debt/Eq- EarningsMay 20 BMO Payout- Avg Volume96.30K Price8.63
Recom1.60 SMA20-1.39% SMA50-1.98% SMA20017.91% Volume11,289 Change3.57%
Apr-20-21Initiated Northland Capital Outperform $15
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
May-06-21 04:01PM  
May-05-21 08:00AM  
May-04-21 09:02AM  
May-03-21 08:00AM  
Apr-29-21 09:03AM  
Apr-27-21 06:06AM  
Apr-26-21 10:25AM  
Apr-14-21 09:03AM  
Mar-25-21 06:30AM  
Mar-24-21 04:06PM  
Mar-11-21 07:00AM  
Mar-08-21 08:00AM  
Mar-01-21 07:00AM  
Feb-23-21 08:30AM  
Feb-22-21 04:02PM  
Feb-16-21 07:30AM  
Jan-25-21 08:00AM  
Nov-18-20 07:00AM  
Nov-17-20 07:00AM  
Nov-11-20 07:00AM  
Nov-04-20 07:00AM  
Nov-02-20 08:00AM  
Oct-13-20 09:00AM  
Oct-06-20 09:00AM  
Sep-08-20 07:00AM  
Sep-03-20 07:26AM  
Sep-02-20 07:00AM  
Aug-26-20 08:37AM  
Aug-25-20 10:21AM  
Aug-24-20 07:00AM  
Aug-12-20 07:24AM  
Jul-29-20 07:00AM  
Jul-21-20 09:00AM  
Jun-24-20 02:09PM  
Jun-16-20 07:30AM  
Jun-09-20 07:30AM  
May-20-20 07:30AM  
May-06-20 07:30AM  
May-04-20 09:00AM  
Apr-13-20 07:30AM  
Apr-07-20 09:00AM  
Mar-23-20 08:00AM  
Mar-11-20 09:00AM  
Mar-04-20 08:16AM  
Feb-20-20 09:00AM  
Feb-10-20 09:00AM  
Feb-06-20 09:39AM  
Feb-04-20 09:00AM  
Jan-21-20 09:00AM  
Jan-16-20 09:00AM  
Dec-02-19 08:27AM  
Nov-25-19 07:00AM  
Nov-14-19 04:01PM  
Nov-12-19 09:00AM  
Oct-29-19 11:00AM  
Oct-16-19 10:00AM  
Oct-01-19 09:00AM  
Sep-24-19 09:00AM  
Sep-19-19 10:10AM  
Sep-12-19 09:00AM  
Sep-10-19 09:00AM  
Aug-26-19 06:30AM  
Aug-14-19 08:00AM  
Aug-07-19 09:00AM  
Jul-25-19 09:00AM  
Jul-18-19 07:00AM  
Jun-27-19 10:01AM  
Jun-24-19 07:00AM  
Jun-17-19 07:00AM  
Jun-13-19 07:00AM  
Jun-05-19 09:00AM  
May-29-19 07:00AM  
May-23-19 07:00AM  
May-22-19 07:00AM  
May-13-19 09:04AM  
May-01-19 09:00AM  
Apr-22-19 04:00PM  
Apr-16-19 08:55PM  
Apr-15-19 04:08PM  
Apr-14-19 09:53AM  
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.